These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 10930856

  • 1. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B, Legrain V, Amoric J, Taïeb A.
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [Abstract] [Full Text] [Related]

  • 2. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC, Kaminester L, Frost P.
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [Abstract] [Full Text] [Related]

  • 3. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW, Grote GD, Williams JL, Tuley MR, Czernielewski JM, Dolak TM, Herndon JH, Baker MD.
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [Abstract] [Full Text] [Related]

  • 4. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W, Oquendo M.
    Skinmed; 2010 Aug; 8(3):150-4. PubMed ID: 21137620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sicorten: a synthetic corticosteroid for topical treatment of common dermatoses.
    Majerus JP, Reiffers-Mettelock J.
    J Int Med Res; 1986 Aug; 14(1):46-9. PubMed ID: 2937673
    [Abstract] [Full Text] [Related]

  • 15. [Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
    Schuppli R, Dressler H, Yawalkar SJ, Weirich EG.
    Z Hautkr; 1983 Feb 15; 58(4):230-7. PubMed ID: 6342285
    [Abstract] [Full Text] [Related]

  • 16. [Treatment with topical corticosteroids in severe or resistant dermatoses].
    Nolting S.
    Derm Beruf Umwelt; 1985 Feb 15; 33(4):140-4. PubMed ID: 2931266
    [Abstract] [Full Text] [Related]

  • 17. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B.
    Clin Dermatol; 2009 Feb 15; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.